ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Kura Oncology Receives Fast Track Designation for Tipifarnib in T-Cell Lymphomas
March 06, 2020Kura Oncology announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the Company’s lead drug candidate, tipifarnib ... -
T-cell lymphomas treatment trial update announced by Innate Pharma
January 13, 2020Enrolment of new patients in the TELLOMAK trial, which has been evaluating the efficacy and safety of lacutamab in patients with advanced T-cell lymphomas, has been suspended.
Pharma Sources Insight January 2025
